These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 31029216)

  • 1. Cefpodoxime proxetil.
    Mostafa GAE; Al-Otaibi YH; Al-Badr AA
    Profiles Drug Subst Excip Relat Methodol; 2019; 44():1-165. PubMed ID: 31029216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piroxicam.
    Mostafa GAE; Al-Dosseri AS; Al-Badr AA
    Profiles Drug Subst Excip Relat Methodol; 2020; 45():199-474. PubMed ID: 32164968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol.
    Al-Badr AA
    Profiles Drug Subst Excip Relat Methodol; 2022; 47():149-326. PubMed ID: 35396014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
    Bhargava S; Agrawal GP
    Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles.
    Khan F; Katara R; Ramteke S
    AAPS PharmSciTech; 2010 Sep; 11(3):1368-75. PubMed ID: 20821175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganciclovir.
    Al-Badr AA; Ajarim TDS
    Profiles Drug Subst Excip Relat Methodol; 2018; 43():1-208. PubMed ID: 29678260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azilsartan medoxomil.
    Al-Majed AA; Bakheit AHH; Al-Muhsin A; Al-Kahtani HM; Abdelhameed AS
    Profiles Drug Subst Excip Relat Methodol; 2020; 45():1-39. PubMed ID: 32164965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lapatinib: A comprehensive profile.
    Abdelgalil AA; Alkahtani HM
    Profiles Drug Subst Excip Relat Methodol; 2023; 48():135-166. PubMed ID: 37061273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin sodium.
    Al-Badr AA; Mostafa GA
    Profiles Drug Subst Excip Relat Methodol; 2014; 39():433-513. PubMed ID: 24794911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione.
    Alanazi AM; Mostafa GA; Al-Badr AA
    Profiles Drug Subst Excip Relat Methodol; 2015; 40():43-158. PubMed ID: 26051685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Spectroscopic studies on drug interaction of cefpodoxime proxetil and H2 receptor blockers.
    Iqbal S; Hassan S; Hassan A; Ali M; Nazim U; Zaheer E; Ahmed A; Hussain K; Shereen -; Furqan H
    Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):881-887. PubMed ID: 31103987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous spectrophotometric determination of Cefpodoxime proxetil and Potassium clavulanate.
    Gandhi SV; Patil UP; Patil NG
    Hindustan Antibiot Bull; 2009; 51(1-4):24-8. PubMed ID: 21268556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam.
    Alrabiah H
    Profiles Drug Subst Excip Relat Methodol; 2019; 44():167-204. PubMed ID: 31029217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate.
    Bajaj A; Rao MR; Khole I; Munjapara G
    Drug Dev Ind Pharm; 2013 May; 39(5):635-45. PubMed ID: 22564007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltammetric behavior of cefixime and cefpodoxime proxetil and determination in pharmaceutical formulations and urine.
    Reddy TM; Sreedhar M; Jayarama Reddy S
    J Pharm Biomed Anal; 2003 Mar; 31(4):811-8. PubMed ID: 12644208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisoprolol: A comprehensive profile.
    Bakheit AH; Ali R; Alshahrani AD; El-Azab AS
    Profiles Drug Subst Excip Relat Methodol; 2021; 46():51-89. PubMed ID: 33461700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefdinir.
    Al-Badr AA; Alasseiri FA
    Profiles Drug Subst Excip Relat Methodol; 2014; 39():41-112. PubMed ID: 24794905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
    Gundogdu E; Koksal C; Karasulu E
    Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.
    Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on physicochemical and biological differences of cefpodoxime proxetil enantiomers.
    Kakumanu VK; Arora V; Bansal AK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):255-9. PubMed ID: 16797950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.